Analytical Quality by Design, Life Cycle Management, and Method Control

Area of Science:

• Pharmaceutical Science
• Analytical Chemistry
• Biotechnology

Background:

• Analytical methods are crucial for biopharmaceutical and vaccine R&D and manufacturing.
• Ensuring continuous data quality for decision-making and risk management is essential.
• Traditional methods face challenges in robust validation and life cycle management.

Purpose of the Study:

• To provide context and implementation details for Analytical Quality by Design (AQbD) in relation to ICH Q14.
• To illustrate the AQbD workflow, its advantages over traditional methods, and pathways for real-time verification.
• To discuss implementation challenges and regulatory strategies for AQbD.

Main Methods:

• The study expands on existing AQbD concepts, referencing ICH Q8, Q9, USP 1220, and ICH Q14.
• Illustrative examples are used to describe the AQbD workflow and its integration with regulatory guidelines.
• Discussion includes comparisons with traditional analytical approaches and real-time verification strategies.

Main Results:

• AQbD provides a systematic framework for developing and managing analytical methods throughout their lifecycle.
• Implementation of AQbD can lead to continuously validated, robust assays.
• The paper outlines potential pathways for ongoing, real-time verification of analytical methods.

Conclusions:

• AQbD is a valuable framework for enhancing analytical method quality and reliability in the biopharmaceutical industry.
• Alignment with ICH Q14 facilitates the implementation and regulatory acceptance of AQbD.
• Addressing implementation challenges and regulatory strategies is key to successful AQbD adoption.